Loading…

Locoregional control and toxicity after pleurectomy/decortication and intensity‐modulated pleural radiation therapy in patients with malignant pleural mesothelioma

Background Treatment of malignant pleural mesothelioma (MPM) represents a major challenge for oncologists. Multimodality treatment, which generally involves induction chemotherapy, surgery and radiotherapy have recently shown promising results. The aim of this study was to evaluate the locoregional...

Full description

Saved in:
Bibliographic Details
Published in:Thoracic cancer 2020-12, Vol.11 (12), p.3448-3455
Main Authors: Arrieta, Oscar, Lozano‐Ruiz, Francisco, Blake‐Cerda, Monika, Catalán, Rodrigo, Lara‐Mejía, Luis, Salinas, Miguel Ángel, Maldonado‐Magos, Federico, Corona‐Cruz, José F.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Treatment of malignant pleural mesothelioma (MPM) represents a major challenge for oncologists. Multimodality treatment, which generally involves induction chemotherapy, surgery and radiotherapy have recently shown promising results. The aim of this study was to evaluate the locoregional control and toxicity of intensity modulated radiotherapy (IMRT) after pleurectomy and decortication (P/D) as part of trimodality therapy for patients with locally advanced MPM. Methods We prospectively analyzed data from 20 patients with MPM treated at a single tertiary‐care institution. Initially every patient received induction chemotherapy with platinum‐based chemotherapy. After chemotherapy, patients without progression underwent P/D, and if feasible, hemi‐thoracic IMRT was administered at a planned dose of 50.4–54 Gy in 28–30 fractions and treated with 9–11 noncoplanar fields. Results A total of 15 of the 20 enrolled patients underwent P/D followed by IMRT to the hemi‐thoracic cavity. The median total radiotherapy dose was 48.7 Gy (23.4–54 Gy). Radiation pneumonitis (RP) developed in nine patients (60%), and of these, two patients (13.3%) experienced G3 or G4 RP. The estimated locoregional‐relapse‐free survival at two years was 75.9%, and the main pattern of recurrence was distant (72.7%). For the entire cohort median follow‐up was 22.7 months, median progression‐free survival was 18.9 months and median overall survival 23.6 months. Conclusions Platinum‐based chemotherapy followed by lung‐sparing surgery (P/D) and IMRT is a feasible and safe treatment modality that yields acceptable locoregional control in patients with locally advanced MPM; however, these results should be corroborated in larger studies. For patients with malignant pleural mesothelioma a less invasive surgical approach than EPP, such as P/D followed by high doses of radiation, in the form of IMRT, could lead to a high rate of locoregional control and acceptable toxicity.
ISSN:1759-7706
1759-7714
DOI:10.1111/1759-7714.13668